Sotac Pharmaceuticals Limited — Others, 08-04-2025: Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

Sotac Pharmaceuticals Limited has confirmed its non-applicability of Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, allowing it to forgo filing quarterly, half-yearly, and yearly Corporate Governance Reports. This is based on the company's classification under Regulation 15(2)(b) due to its listing on the National Stock Exchange SME Emerge Platform.

The implications of this announcement may streamline reporting processes and reduce administrative burdens, potentially improving operational efficiency. For investors, this could signify a positive outlook as the company maintains compliance benefits while focusing on growth strategies without additional governance reporting pressures.